Skip to main content
Premium Trial:

Request an Annual Quote

Clondiag, CyBio to Launch Lab Diagnostics Instruments

NEW YORK, Feb. 2 (GenomeWeb News) - German bioarray firm Clondiag and CyBio will co-develop automatic pipetting and analyzing instruments for use in lab diagnostics, the companies announced today.

 

Aided by CyBio's resources, Clondiag will introduce its Clondiag ArrayStripProcessor, a package of 20 devices which it claims will eliminate user intervention in the pipetting, incubation, washing, selection, visualization, and data-management processes.

 

The product will be used for biochips with a 96-well microplate format. The first run of the new ASP package will be available in the second quarter.

 

Matthias Voigt, project manager for CyBio, told GenomeWeb News that his company has signed onto a 2-year agreement with Clondiag and has promised to deliver a minimum of 100 devices in that period for a fixed price.

 

He said Clondiag would market the new products to its customers in the biotechnology field.

 

Clondiag said in a statement that it aims to market the fully automated ASP to compliment the use of its biochip technology in molecular and immunological diagnostics, as well as genomic and serologic analytics.

 

Financial terms of the agreement were undisclosed. Both companies are based in Jena, Germany.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.